Mitral regurgitation caused by chronic ergotamine use

American Heart Journal

Volumn 131, Issue 3, 1996, Pages 603-606

  Flaherty, Kevin R ^b   Bates, John R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERGOTAMINE TARTRATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIARRHEA; DISEASE SEVERITY; ERGOTISM; FEMALE; HUMAN; MIGRAINE; MITRAL VALVE REGURGITATION; MYALGIA; NAUSEA; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

EID: 0029968081     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90544-X     Document Type: Article

References (6)

1. Bennett DR. Volume 1: drugs used for headache and neuralgias. In: Bennett DR, ed. Drug evaluations subscription. Chicago, Ill.: American Medical Association, 1990.
2. Redfield MM, Nicholson WJ, Edwards WD, Tajik AJ. Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations. Ann Intern Med 1992;117:50-2.
3. Hauck AJ, Edwards WD, Danielson GK, Mullany CJ, Bresnahan DR. Mitral and aortic valve disease associated with ergotamine therapy for migraine. Arch Pathol Lab Med 1990;114:62-4.
4. Austin SM, El-Hayek A, Comianos M, Tamulonis DJ. Mitral valve disease associated with long-term ergotamine use. South Med J 1993; 86:1179-81.
5. Bana DS, MacNeal PS, LeCompte PR, Shah Y, Graham JR. Cardiac murmurs and endocardial fibrosis associated with methysergide treatment. AM HEART J 1974;88:640-55.
6. Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, Kvols LK. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation 1993;87:1188-96.